2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Melanoma
36
Carcinoma, Renal Cell
16
Prostatic Neoplasms
10
Neoplasm Metastasis
10
Leukemia, Myeloid, Acute
9
Carcinoma, Non-Small-Cell Lung
9
Uveal Melanoma
8
Myelodysplastic Syndromes
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Clear-cell metastatic renal cell carcinoma
7
Lymphoma, Non-Hodgkin
6
Lung Neoplasms
6
Hematologic Neoplasms
6
Triple Negative Breast Neoplasms
5
Sarcoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Ovarian Neoplasms
5
Multiple Myeloma
5
Hodgkin Disease
5
Breast Neoplasms
5
Brain Neoplasms
5
Uterine Cervical Neoplasms
4
Pancreatic Neoplasms
4
Lymphoma, Follicular
4
Histiocytoma, Malignant Fibrous
4
Gastrointestinal Stromal Tumors
4
Burkitt Lymphoma
4
Urinary Bladder Neoplasms
3
Urethral Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Interventions
enzalutamide
20
Abiraterone Acetate
11
Prednisone
7
Docetaxel
7
radium Ra 223 dichloride
6
darolutamide
5
abiraterone
5
apalutamide
3
olaparib
2
niraparib
2
cabazitaxel
2
atezolizumab
2
Pluvicto
2
Nivolumab
2
zimberelimab
1
xentuzumab
1
tasquinimod
1
sacituzumab govitecan
1
sabizabulin
1
quemliclustat
1
pembrolizumab
1
ipatasertib
1
ibrutinib
1
gedatolisib
1
gallium 68 PSMA-11
1
fludrocortisone acetate
1
TVB-2640
1
Standard of Care
1
Rosuvastatin Calcium
1
Radium-223
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms, Castration-Resistant
×
CTLA-4 Antigen
×
Clear all
NCT04717154
2026-01-06
INSPIRE
Radboud University Medical Center
Phase 2
Completed
69 enrolled